New York, NY -- (SBWIRE) -- 07/11/2019 -- The market for conjugate vaccines is expected to increase, owing to global awareness about the benefits of vaccination for the prevention of certain life-threatening diseases, growing initiatives for production of low-cost vaccines, and widespread routine vaccination programmes in emerging economies. The market will witness a steady growth, expanding at a compound annual growth rate (CAGR) of 11.7% during 2017-2022, to reach approximately USD 87.7 Bn by 2022.

To Know More about Conjugate Vaccines Market Get Free Sample Copy of this Report @ https://www.marketexpertz.com/sample-enquiry-form/43436

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
1. GlaxoSmithKline
2. Pfizer Inc.
3. Merck & Co.
4. Novartis
5. Sanofi Pasteur
6. CSL Limited
7. Bharat Biotech International
8. Biological E Limited
9. Serum Institute of India
Customizations available

Disease indication segment insights:
Pneumococcal conjugate vaccine (PCV) held the largest market share (24.66%) in 2017 owing to the widespread nature of pneumococcal disease. Also, the leading vaccine-preventable cause of death among children around the world is the pneumococcal disease. Global initiatives were undertaken to speed up the introduction of pneumococcal vaccinations in low-income countries through partnerships among countries, donors, academia, international organizations, and industries. Close on its heels, the diphtheria and tetanus toxoids and pertussis (DTP) conjugate vaccine occupied a share of 23% in 2017. The higher prevalence of respiratory diseases such as whooping cough, among both children and adults, have led to the increased adoption of DTP conjugate vaccines. Haemophilus influenzae type b (Hib) conjugate vaccines are expected to grow at the fastest rate during 2017-2022.

#Conjugate Vaccines Market Report to grow your business needs and avail 15% free customization on the report: Now Purchase @ https://www.marketexpertz.com/checkout-form/43436

End user segment insights:
The adult segment registered higher market share than the paediatric segment because of an increase in awareness on conjugate vaccines for adults, over the years. Still, the penetration level for adult conjugate vaccines is comparatively lower, with the lowest being for PCVs. Hence, the growth potential is very high. The paediatric vaccines, on the other hand is a stable market and depends highly on the birth rates in each region. The vaccination programmes, especially taken up by global organizations such as the United Nations Educational, Scientific and Cultural Organization (UNESCO), have been successful in eradicating many such vaccine-preventable diseases.

Regional insights:
Asia-Pacific is the largest market for conjugate vaccines, which held a share of 42%, in 2017. The primary indicators of the potential for the vaccine market is the geriatric population in the region, especially in countries such as India and China. In turn, this has, encouraged market participants to increase spending on research and development (R&D) and distribution facilities in the these countries. North America is the second biggest market for conjugate vaccines, owing to the region's widespread immunization programmes. The Middle East and Africa, and Latin America regions lack proper infrastructure and awareness of vaccine-preventable diseases, which are hindering market growth.

The report analyses key geographies, including the USA, UK, Europe, Asia Pacific, and Latin America. The leading players in the Conjugate Vaccines Market and their regional presence across the globe are estimated on factors like production capacity, utilization ratio, consumer base, demand, and supply chain, profit margin, and merchants. Additionally, the Conjugate Vaccines market research report also gives an in-depth analysis of the following aspects:

Interested in this Conjugate Vaccines market report? Get your FREE sample now! https://www.marketexpertz.com/sample-enquiry-form/43436

In market segmentation by geographical regions, the report has analysed the following regions-
- North America
- Europe
- China
- Japan
- Middle East & Africa
- India
- South America
- Others

There are 15 Chapters to deeply display the global Conjugate Vaccines market.
- Chapter 1, to describe Conjugate Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
- Chapter 2, to analyze the top manufacturers of Conjugate Vaccines, with sales, revenue, and price of Conjugate Vaccines, in 2017 and 2018;
- Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
- Chapter 4, to show the global market by regions, with sales, revenue and market share of Conjugate Vaccines, for each region, from 2014 to 2018;
- Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
- Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2014 to 2018;
- Chapter 12, Conjugate Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
- Chapter 13, 14 and 15, to describe Conjugate Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

The research provides answers to the following key questions:
- What will be the growth rate of the Conjugate Vaccines market for the forecast period, 2018 - 2023? What will be the market size for the estimated period?
- What are the prominent factors driving the Conjugate Vaccines market across different regions?
- Who are the major vendors dominating the Conjugate Vaccines industry and what are their winning strategies?
- What are the major trends shaping the development of the industry in the coming years?
- What are challenges faced by the Conjugate Vaccines market?
- What are potential opportunities for the industry for the forecast period, 2018 - 2023?

If you have any special requirements, please let us know and we will offer you the report as you want.

View Full Report Description with Table of Content@ https://www.marketexpertz.com/industry-overview/conjugate-vaccines-market

About MarketExpertz
Planning to invest in market intelligence products or offerings on the web? Then marketexpertz has just the thing for you - reports from over 500 prominent publishers and updates on our collection daily to empower companies and individuals catch-up with the vital insights on industries operating across different geography, trends, share, size and growth rate. There's more to what we offer to our customers. With marketexpertz you have the choice to tap into the specialized services without any additional charges.

Contact Us:
John Watson
Head of Business Development
Market Expertz | Web: www.marketexpertz.com
Direct Line: +1-800-819-3052
E-mail: sales@marketexpertz.com
News: www.marketexpertz.com/market-news